Literature DB >> 25550182

An endoscopic Mayo score of 0 is associated with a lower risk of colectomy than a score of 1 in ulcerative colitis.

Claire Manginot1, Cédric Baumann2, Laurent Peyrin-Biroulet3.   

Abstract

Entities:  

Keywords:  SURGERY FOR IBD; ULCERATIVE COLITIS

Mesh：

Year:  2014        PMID： 25550182     DOI： 10.1136/gutjnl-2014-308839

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  15 in total

1.  Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.

Authors:  Neeraj Narula; Farhad Peerani; Joseph Meserve; Gursimran Kochhar; Khadija Chaudrey; Justin Hartke; Prianka Chilukuri; Jenna Koliani-Pace; Adam Winters; Leah Katta; Eugenia Shmidt; Robert Hirten; David Faleck; Malav P Parikh; Diana Whitehead; Brigid S Boland; Siddharth Singh; Sashidhar Varma Sagi; Monika Fischer; Shannon Chang; Morris Barocas; Michelle Luo; Karen Lasch; Matthew Bohm; Dana Lukin; Keith Sultan; Arun Swaminath; David Hudesman; Nitin Gupta; Bo Shen; Sunanda Kane; Edward V Loftus; Corey A Siegel; Bruce E Sands; Jean-Frederic Colombel; William J Sandborn; Parambir S Dulai
Journal:  Am J Gastroenterol       Date:  2018-06-27       Impact factor: 10.864

2.  Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy.

Authors:  Marcello Cintolo; Giuseppe Costantino; Socrate Pallio; Walter Fries
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

3.  Complete histologic normalisation is associated with reduced risk of relapse among patients with ulcerative colitis in complete endoscopic remission.

Authors:  Kelly C Cushing; William Tan; David H Alpers; Vikram Deshpande; Ashwin N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2019-11-07       Impact factor: 8.171

4.  Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.

Authors:  Caroline Prieux-Klotz; Stéphane Nahon; Aurelien Amiot; Leila Sinayoko; Carole Galéano-Cassaz; Stanislas Chaussade; Romain Coriat; Pierre Lahmek; Vered Abitbol
Journal:  Dig Dis Sci       Date:  2016-11-16       Impact factor: 3.199

Review 5.  Current Endpoints of Clinical Trials in Ulcerative Colitis: Are They Valid?

Authors:  Robert Battat; Parambir S Dulai; Christopher Ma; Vipul Jairath; Brian G Feagan; William J Sandborn; Reena Khanna
Journal:  Curr Treat Options Gastroenterol       Date:  2020-01-04

6.  Does Medical Acceleration Improve Outcomes in Ulcerative Colitis Patients Who Are in Clinical Remission but Have Endoscopic Inflammation?

Authors:  Ji Young Chang; Jae Hee Cheon; Yehyun Park; Soo Jung Park; Tae-Il Kim; Won-Ho Kim
Journal:  Dig Dis Sci       Date:  2018-07-09       Impact factor: 3.199

7.  Mucosal Healing in Crohn's Disease and Ulcerative Colitis.

Authors:  Laurent Peyrin-Biroulet
Journal:  Gastroenterol Hepatol (N Y)       Date:  2020-04

8.  Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitis.

Authors:  Parambir S Dulai; Siddharth Singh; Vipul Jairath; Christopher Ma; Neeraj Narula; Niels Vande Casteele; Laurent Peyrin-Biroulet; Severine Vermeire; Geert D'Haens; Brian G Feagan; William J Sandborn
Journal:  Aliment Pharmacol Ther       Date:  2019-11-22       Impact factor: 8.171

9.  Etrolizumab for the Treatment of Ulcerative Colitis and Crohn's Disease: An Overview of the Phase 3 Clinical Program.

Authors:  William J Sandborn; Severine Vermeire; Helen Tyrrell; Azra Hassanali; Stuart Lacey; Swati Tole; Amanda R Tatro
Journal:  Adv Ther       Date:  2020-05-22       Impact factor: 3.845

10.  Practical fecal calprotectin cut-off value for Japanese patients with ulcerative colitis.

Authors:  Jun Urushikubo; Shunichi Yanai; Shotaro Nakamura; Keisuke Kawasaki; Risaburo Akasaka; Kunihiko Sato; Yosuke Toya; Kensuke Asakura; Takahiro Gonai; Tamotsu Sugai; Takayuki Matsumoto
Journal:  World J Gastroenterol       Date:  2018-10-14       Impact factor: 5.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.